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Viral replication requires energy and macromolecular precursors derived from the metabolic network of the host cell.
Despite this reliance, the effect of viral infection on host cell metabolic composition remains poorly understood. Here
we applied liquid chromatography-tandem mass spectrometry to measure the levels of 63 different intracellular
metabolites at multiple times after human cytomegalovirus (HCMV) infection of human fibroblasts. Parallel microarray
analysis provided complementary data on transcriptional regulation of metabolic pathways. As the infection
progressed, the levels of metabolites involved in glycolysis, the citric acid cycle, and pyrimidine nucleotide
biosynthesis markedly increased. HCMV-induced transcriptional upregulation of specific glycolytic and citric acid cycle
enzymes mirrored the increases in metabolite levels. The peak levels of numerous metabolites during infection far
exceeded those observed during normal fibroblast growth or quiescence, demonstrating that HCMV markedly disrupts
cellular metabolic homeostasis and institutes its own specific metabolic program.
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Introduction
Host cells provide viruses with the metabolic resources
necessary for their replication. Viral replication requires bulk
macromolecule synthesis, which depends on a substantial
supply of biopolymer subunits and energy for their assembly.
Anti-viral compounds that target viral utilization of macro-
molecular precursors, such as nucleotide analogs, have
proven to be successful clinical treatments. Notwithstanding
these therapeutic successes, the mechanisms through which
viruses engage and manipulate the small molecule metabolic
network of host cells remain largely a mystery.
Human cytomegalovirus (HCMV) is a prototypical b-herpes
virus family member. Epidemiological studies have demon-
strated that the virus is widespread, infecting more than half
of the earth’s population [1]. Most healthy adults undergo an
asymptomatic infection, during which the virus enters a
latent state for the life of its host. However, primary infection
or reactivation of latent HCMV causes life-threatening
disease in immunologically immature or compromised
individuals. In addition, HCMV is the leading known
infectious cause of birth defects; congenital infection can
result in multiple organ system abnormalities with damage to
the auditory system occurring in the majority of symptomatic
newborns [1].
Like all herpesviruses, the HCMV particle is enveloped and
contains a large double-stranded DNA genome packaged
inside a protein capsid. The capsid in turn is surrounded by a
protein tegument layer residing between the capsid and the
envelope.
HCMV infection induces total RNA and protein synthesis
in infected cells [2,3]. However, it remains unclear to what
extent HCMV infection perturbs small molecule metabolism
to accomplish the macromolecular synthesis needed for viral
replication. Here we used liquid chromatography-tandem
mass spectrometry (LC-MS/MS) to measure the levels of 63
different intracellular metabolites during HCMV infection of
cultured ﬁbroblasts. Additionally, to provide insight into
potential transcriptional activation of metabolic pathways,
we conducted mRNA expression proﬁling in parallel.
We ﬁnd that as infection progresses, the levels of numerous
metabolic components in pathways such as glycolysis, the
tricarboxylic acid (TCA) cycle, and pyrimidine biosynthesis
markedly increase. Mirroring our metabolomics data, HCMV
transcriptionally activates genes encoding components of the
TCA cycle, glycolytic pathway, and certain aspects of the
pyrimidine biosynthetic pathway. The peak levels of various
metabolites during infection far exceed those observed
during normal ﬁbroblast growth or quiescence, indicating
that HCMV markedly disrupts metabolic homeostasis.
Results/Discussion
Cell Handling and Metabolite Extraction
LC-MS/MS data on 167 different metabolites were collected
at various times following infection with HCMV or a mock
negative control innoculum. Fibroblasts were grown to
conﬂuence and then maintained in serum-free medium for
24 h prior to infection. This treatment served to synchronize
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in response to infection [4]. Additionally, the use of serum-
free medium removes a complex source of extraneous
metabolites from the analysis. Cells were assayed at 4, 24,
48, 72, and 96 h post infection (hpi) to provide coverage
during the extended replication cycle of HCMV. In cultured
ﬁbroblasts, viral gene expression is ﬁrst detected at about 2
hpi, viral DNA replication begins between 24–30 hpi, and
peak virus yields are achieved between 72–96 hpi, after which
the cells die.
At the appropriate time post infection, medium was
aspirated from the cells (a thin ﬁlm of medium remains
covering the cells due to surface tension effects, avoiding
alteration of the immediate cellular environment) and 75 8C
methanol was immediately added to quench metabolic
activity and extract metabolites. Given the speed of metabolic
reactions, quickly removing medium and immediately
quenching metabolism is essential for obtaining reliable
results; we have found that even a single wash step leads to
substantial changes in metabolome composition. The selec-
tion of cold methanol as an extraction solvent was based on
systematic studies in bacteria and yeast, which point to its
providing relatively good extraction of a broad spectrum of
metabolites [5–7], while avoiding marked metabolite decom-
position and associated formation of decomposition prod-
ucts, which can themselves mimic metabolites [8]. A
contributor to the efﬁcacy of  75 8Cm e t h a n o la sa n
extraction solvent is likely its disrupting membranes by
inducing formation of microscopic ice crystals.
Metabolite Quantitation
Extracted metabolites were measured via LC-MS/MS, with
the LC separation involving hydrophilic interaction chroma-
tography on an aminopropyl resin at basic pH, an approach
tailored to quantitation of water-soluble cellular metabolites
[9]. Each metabolite measurement was in the form of a
selected reaction monitoring scan event (SRM); formation
within the mass spectrometer collision cell of a particular
molecular weight product ion from a speciﬁc molecule weight
parent ion by gas phase collision of the parent ion with argon
occurring at a speciﬁc chromatographic retention time.
These SRMs were designed based on prior knowledge of the
retention time and mass spectrometry fragmentation pattern
of a puriﬁed standard of the metabolite of interest [6], with a
one-to-one correspondence between metabolites and SRMs.
An exception to the one-to-one relationship between
metabolites and SRMs was the co-elution of certain metab-
olite isomers yielding identical fragmentation patterns (e.g.,
different isomers of glucose-6-phosphate, which we refer to
collectively as hexose-phosphate).
In many cases, no useful quantitative data were obtained,
due to the metabolite never being present in detectable
amounts or being present in the medium at such high levels
as to interfere with analysis. For 63 metabolites, however,
reliable quantitative data were obtained in the form of ion
counts from compound-speciﬁc SRM chromatograms (for
details on the requirements for metabolite inclusion see
Materials and Methods). These 63 metabolites included a
variety of key components of central carbon metabolism and
nucleotide metabolism, including multiple phosphorylated
compounds such as ATP and fructose bisphosphate (FBP).
Internal Standards
To ensure that experimental artifacts such as ion suppres-
sion did not lead to misinterpretation of metabolite levels,
isotope-labeled internal standards were added to every
sample. As is typical for electrospray ionization-mass spec-
trometry data, there are occasional ﬂuctuations in the
internal standard signals, generally in the range of ;20%
(Figure S2), which is much smaller than the effects due to viral
infection described below. As the ﬂuctuations generally
occurred in parallel for the mock versus viral samples and
did not follow any systematic pattern with respect to viral
versus mock treatment (Figure S2), there is no evidence of
systematic error between mock and viral samples due to ion
suppression or other electrospray ionization-mass spectrom-
etry artifacts. Accordingly, experimental error in the LC-MS/
MS measurement is very unlikely to have inﬂuenced the
biological conclusions of the present work.
Data Normalization and Presentation
To enable cross-sample comparison of metabolite (ion
count) signals, the observed signal was normalized with
respect to the total protein content of the cells used to
generate the sample. Protein content, rather than cell
number, was used for normalization because HCMV-infected
cells increase approximately 2-fold in volume as compared to
mock-infected cells. Normalization with respect to protein
content should yield signals in units approximating ion
counts/cell volume, which for any given metabolite is linearly
proportional to its intracellular concentration [9]. Compar-
ison of ion counts across compounds is complicated by
compound-speciﬁc ionization efﬁciencies. Accordingly, sig-
nals were further normalized to the initial (t ¼ 4 h) signal in
the mock-infected condition.
Time course data for compounds or pathways of particular
interest are shown in Figures 1–6, and complete data
(including absolute ion counts) on the 63 quantiﬁable
metabolites are provided in Table S1. RNA expression data
were collected by microarray analysis, and data for key
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Synopsis
Viruses are parasites. They depend on the biochemical infrastructure
of host cells to grow. A key element of the infrastructure provided
by the host cell is its metabolic machinery, which viruses rely upon
to provide the energy and building blocks necessary for their
replication. The way in which viruses interact with host cell
metabolism remains, however, poorly understood. The authors
have used an advanced measurement technique, liquid chromatog-
raphy-mass spectrometry, to quantitate directly the levels of a large
number of metabolic compounds (energy molecules and biochem-
ical building blocks) during cytomegalovirus infection of cultured
human cells. They find that viral infection leads to dramatic increases
in the levels of many metabolites and that these increases
substantially exceed those associated with normal transitions of
cells between resting and growing states. In several cases, enhanced
metabolite levels induced by the virus coincide with an apparent
increase in host cell production of the machinery (enzymes) involved
in making those metabolites. This work represents the first
comprehensive characterization of the metabolic environment of
virally infected cells and identifies a number of profound metabolic
effects of the virus, some of which may eventually prove fruitful
targets for antiviral therapy.metabolic enzymes that changed signiﬁcantly upon infection
are shown in Figure 7. The primary expression data are
provided in full via the Princeton University MicroArray
database (http://puma.princeton.edu/index.shtml). In certain
speciﬁc cases, we validated our microarray data using
quantitative PCR (qPCR) (Figure 2A).
General Strategies for Data Interpretation
Before addressing particular experimental observations, it
is useful to consider the different potential causes of
particular metabolite level changes. Consider the following
metabolic pathway:
A ! B ! C
Increased intracellular levels of a given metabolite B can
arise from either increased ﬂux from A ! B, or decreased
ﬂux from B ! C. These alternatives can likely best be
distinguished using isotope tracers; however, in the absence
of such tracer data (which will not be presented here), good
estimates of the true cause of a change in the level of
metabolite B can often be made based on knowledge of key
regulated steps in metabolic pathways. That is, if the reaction
A ! B but not B ! C is known to be a key regulated step,
then change in ﬂux through A ! B likely accounts for the
change in the level of B. For example, in Figure 1 we report
an increase in FBP at 48 hpi. As production of FBP via
phosphofructose kinase-1(PFK-1) is tightly regulated [10–12],
whereas consumption of FBP by aldolase is not, the most
likely cause of the increase in FBP is increased PFK-1 ﬂux.
This conclusion is reinforced by the observation that levels of
the aldolase product, dihydroxyacetone phosphate (DHAP),
increase roughly in parallel with those of FBP (if the increase
in FBP were due to blockade of aldolase, DHAP levels should
drop, not increase). It is conﬁrmed by direct measurement of
PFK activity from cell lysates, as described further below
(Figure 2B).
The above analysis considers only the two most basic causes
of changes in the level of metabolite B: altered consumption
or production via a linear pathway. It is worth noting that
especially in a highly compartmentalized eukaryotic cell,
other situations can arise. For example, imagine that the
reactions A ! B ! C normally occur in a subcellular
compartment that upon viral infection begins to leak B into
the cytosol, which contains no enzyme that consumes B. In
this case, increased levels of B may occur independently of
ﬂux increases or decreases via the standard A! B ! C
reaction pathway, depending instead on the extent of B
leakage. Such a case may describe the pyrimidine pathway
intermediate carbamoyl-aspartate, as will be discussed later.
We wish to emphasize that while transport of metabolites
between subcellular compartments may play a key role in
Figure 1. HCMV-Induced Changes in Glycolytic Metabolites
Replicate cultures of confluent fibroblasts were serum-starved for 24 h and subsequently mock- infected (dotted line) or virally infected at a multiplicity
of 3.0 pfu/cell with HCMV (red line). Cells were harvested at 4, 24, 48, 72, and 96 hpi and processed for LC-MS/MS. SRM peak heights from two
independent experiments performed in duplicate (n¼4) were normalized to protein levels. Average fold change in the metabolite level (relative to the
mock 4-h sample) is plotted on a log2 axis. Error bars show 6 1 SE of the mean. Transcriptional data are depicted graphically at the relevant enzymatic
step by the following symbols (shown in red):þ, increased and , decreased  1.5-fold in HCMV infection versus mock infection and p , 0.05 based on
ANOVA analysis; NC, no change, either not significant by ANOVA or effect of HCMV , 1.5-fold. Enzyme names are also provided, with those increased
transcriptionally listed in bold and those decreased in italics. Transcriptional data represent an average across 24, 48, and 72 h and specific enzyme
isoforms/subunits.
doi:10.1371/journal.ppat.0020132.g001
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Metabolomics of HCMV Infectionregulation of mammalian metabolism, our current analytical
approach provides only average metabolite levels throughout
the full cellular volume. Accordingly, the pathway diagrams in
the ﬁgures include only covalent, not transport, reactions.
Effect of HCMV Infection on Upper Glycolysis
Glycolysis and the TCA cycle oxidize hexose sugars to form
ATP and NADH, the major energy currencies of the cell.
While HCMV infection has been previously shown to
stimulate glucose uptake in ﬁbroblasts [13], its detailed effect
on intracellular carbon metabolism has not been previously
investigated.
We found that early during infection (i.e., 4–24 hpi), there
was little difference in measurable glycolytic pathway
metabolites between mock- and HCMV-infected ﬁbroblasts
(Figure 1). Beginning at 48 hpi, however, differences emerged:
FBP, DHAP, 3-phosphogylcerate, and phosphoenolpyruvate
(PEP) increased relative to mock infection (Figure 1).
The increased levels of glycolytic intermediates during
HCMV infection correlated with an increase in the transcript
levels of several glycolytic enzymes (Figures 1 and 7). One
such enzyme, PFK-1, is the key upstream regulator of
glycolytic ﬂow [14–16]. To verify our microarray results
regarding this important regulatory enzyme, we analyzed its
transcript levels over the course of infection by qPCR.
Transcript levels were found to be increased at every time
point assayed with a peak 6-fold increase at 48 hpi (Figure
2A). The levels of PFK-19s product, FBP, also peaked at this
time, suggesting increased PFK-1 activity in HCMV-infected
cells at 48 hpi. To directly test for such activity, we performed
biochemical assays on cell lysates. Addition of fructose-6-
phosphate and ATP to lysates of HCMV-infected or mock-
infected cells resulted in accumulation of FBP, with the initial
rate of accumulation ;4-fold greater for HCMV than mock
infection. Since PFK-1 regulates glycolytic ﬂow, the increased
levels of downstream glycolytic intermediates during HCMV
infection likely reﬂect, at least in part, this increase in PFK-1
activity.
Glycolytic Efflux during HCMV Infection
Most of the measured glycolytic intermediates increased at
48 hpi relative to their status in mock-infected cells. However,
the increase in FBP was transient, presumably due to its rapid
conversion to downstream glycolytic intermediates. The
terminal glycolytic metabolite, PEP, increased from 48 hpi
onward (Figure 1). This suggested the presence of a bottle-
neck to glycolytic efﬂux at the level of pyruvate kinase late in
infection. Such a bottleneck could arise from decreased
maximum velocity for the pyruvate kinase reaction (e.g., due
to decreased pyruvate kinase levels), increased Km of the
enzyme for PEP (e.g., due to allosteric regulation or shift to a
higher Km isozyme), or failure of pyruvate kinase activity to
keep pace with increased ﬂux through upper glycolysis. Our
microarray data revealed increased expression of enzymes
linking FBP to PEP (triose phosphate isomerase, phosphogly-
cerate kinase, and enolase) but decreased expression of
pyruvate kinase (Figures 1, 2A, and 7). This decrease in
pyruvate kinase transcript is consistent with (and may
potentially cause) the observed accumulation of PEP. Note
that the reactions linking DHAP to PEP are associated with
net DG
09; zero [17]. Thus, irrespective of the activities of the
intervening enzymes, DHAP and its products must accumu-
late in parallel with PEP for glycolysis to continue to run in
the net forward direction.
The principal carbohydrate product of glycolysis is
pyruvate, which was not measured here due to its poor
fragmentation in MS/MS. A key metabolite of pyruvate is
alanine, which is produced via pyruvate transamination.
Levels of alanine increase markedly starting at 48 hpi (Figure
3), in concert with the increase in FBP and other glycolytic
intermediates (Figure 1). Much like PEP, alanine levels grow
steadily from 48 hpi onward. This suggests that overall
glycolytic ﬂux (as reﬂected in part by alanine production) is
increased from 48 hpi onward, with shifting enzymatic
Figure 2. HCMV-Induced Changes in Metabolic Enzyme Activity and
Transcript Levels
(A) Levels of metabolic mRNA transcripts during HCMV infection.
Transcript levels for phosphofructokinase-1(PFK), pyruvate kinase (PK),
and pyruvate dehydrogenase (PDH) were assayed at 24, 48, and 72 h
post-mock or post-HCMV infection by qPCR. Bars represent the mean
levels (n ¼ 2) in the HCMV-infected cells divided by those in the mock-
infected cells at the indicated time point, with the error bars showingþ1
SD of the mean.
(B) HCMV induction of phosphofructokinase activity. FBP accumulation
was measured in mock-infected (dotted line) and HCMV-infected (red
line) cellular lysates collected at 48 hpi. Similar results were found in
three independent experiments.
doi:10.1371/journal.ppat.0020132.g002
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Metabolomics of HCMV Infectionactivity in lower glycolysis altering the balance of FBP versus
PEP during this period.
Intriguingly, two common features of human cancers are
the activation of phosphofructokinase activity mediated by
increased F2,6P accumulation and the expression of a
particularly low-activity isozyme of pyruvate kinase
[11,18,19]. Thus, increased phosphofructokinase activity and
decreased pyruvate kinase activity, which together may favor
use of glycolytic intermediates for production of biosynthetic
building blocks, appear to be shared between cancer and
HCMV infection.
Increased Acetyl-CoA during HCMV Infection
Acetyl-CoA occupies a central position in metabolism. It is
the link between glycolysis and the TCA cycle, as well as a hub
for fatty acid and amino acid oxidation and de novo lipid
biosynthesis. Like alanine, acetyl-CoA can be formed from
pyruvate, and like alanine, acetyl-CoA increased dramatically
throughout HCMV infection; however, acetyl-CoA is unique
in rising even before glycolytic intermediates and ultimately
increasing by ;8-fold in infected as compared to uninfected
cells (Figure 3). The strength of the acetyl-CoA response, as
well as its initiation prior to evidence of increased glycolytic
intermediates, suggests the possibility of increased activity of
the key acetyl-CoA producing enzyme complex, pyruvate
dehydrogenase. Consistent with this notion, pyruvate dehy-
drogenase transcript levels were upregulated 2- to 3-fold by
thevirusbothby microarray(Figure7)andbyqPCR(Figure2).
TCA Intermediates during HCMV Infection
When acetyl-CoA enters the TCA cycle, it is converted, with
the addition of oxaloacetate, into citrate. Throughout
infection, the levels of many TCA cycle constituents were
increased with respect to mock infection; however, citrate
levels were not, although citrate levels did increase in parallel
in both mock- and virus-infected samples (Figure 3). Citrate
Figure 3. HCMV-Induced Changes in the TCA Cycle
Metabolite data from mock-infected (dotted line) or virally infected (red line) fibroblasts are plotted, with the symbolsþand NC (shown in red) over the
arrows indicating changing levels of enzyme transcripts as described in the Figure 1 legend.
doi:10.1371/journal.ppat.0020132.g003
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Metabolomics of HCMV Infectionsynthase activity is inhibited by increased levels of NADH and
succinyl-CoA [20], the levels of which are elevated during
HCMV infection (Figure 3), potentially preventing accumu-
lation of citrate (Figure 3). Alternatively, oxaloacetate may be
diverted via aspartate into de novo pyrimidine synthesis,
which is activated during HCMV infection (Figure 4), thus
limiting its availability for citrate synthesis; direct oxaloace-
tate measurement here was precluded by oxaloacetate
instability [9]. More likely, however, citrate synthase ﬂux was
increased as a consequence of increased acetyl-CoA levels,
but citrate levels were kept steady by increased activity of the
citrate-consuming enzyme, aconitase, whose mRNA level
increased during HCMV infection (Figure 7). Consistent with
increased aconitase expression, aconitate (4-fold increased at
24 and 48 hpi) and its downstream TCA cycle products,
including succinyl-CoA and malate, increased during infec-
tion (Figure 3). Because succinyl-CoA is the entry point for
odd-numbered fatty acid chains into central carbon metab-
olism, its particular strong induction hints at the possibility
of increased fatty acid catabolism induced by the virus.
Transcriptionally, the expression levels of malic enzyme and
malate dehydrogenase both increased (Figure 7). Malic
enzyme converts malate to pyruvate, potentially contributing
to increased alanine and acetyl-CoA levels and limiting
citrate levels, whereas malate dehydrogenase produces
oxaloacetate from malate, thus completing the TCA cycle
by providing citrate synthase with oxaloacetate.
The primary recipient of the energy released from citric
acid cycle oxidations is the reduced electron carrier NADH.
Consistent with elevated glycolysis and citric acid cycle
activity, NADH levels increased approximately 2- to 4-fold
relative to mock infection at every time assayed after 4 h
(Figure 3). This increase in NADH was unlikely to be due to
reduced NADH consumption, as enzymes of the electron
transport chain and the ATP-synthesizing proton pump were
markedly transcriptionally upregulated (Table S2). Taken
together, these results are most consistent with the hypothesis
that HCMV infection stimulates both glycolytic and pyruvate
dehydrogenase ﬂux. This could generate the observed high
level of acetyl-CoA, which was then used to drive the TCA
cycle to produce NADH and eventually ATP, as well as
potentially also donating carbon units to lipid biosynthesis,
which was not explored here.
Dynamics of Central Carbon Metabolites in the Absence
of HCMV
The levels of certain compounds, e.g., citrate, aconitate,
and alanine, increased during mock infection (Figure 3). The
levels of other compounds, e.g., FBP and NADH, decreased
(Figures 1 and 3). As the cellular medium was not changed
during the course of infection, these changes may reﬂect
alteration of the cellular nutrient environment over time,
perhaps due to glucose becoming less abundant and glycolytic
waste products accumulating. Alternatively, the changes in
metabolite levels may reﬂect long-term adaptations of
ﬁbroblasts to tissue culture. One effect of HCMV infection
may be to accelerate some of these processes that occur even
in its absence; however, acceleration of normal physiological
processes is inadequate to account fully for the profound and
persistent changes seen in many compounds such as acetyl-
CoA and NADH.
HCMV Manipulation of Pyrimidine Biosynthesis
HCMV infection stimulates total RNA and DNA synthesis
and increases the total number of cellular ribosomes without
degrading host cell chromosomal DNA [2]. Consequently, the
virus must induce substantial de novo nucleotide biosyn-
thesis. The ﬁrst three steps of pyrimidine biosynthesis are
catalyzed in eukaryotes by a homo-trimer of the 230-kDa
protein termed carbamoyl phosphate synthetase-aspartate
transcarbamoylase-dihydroorotase (CAD), which catalyzes the
synthesis of carbamoyl-phosphate, carbamoyl-aspartate, and
dihydroorotate [21–23]. Carbamoyl-phosphate levels re-
mained relatively similar in mock-infected cells versus
HCMV-infected cells until 72 h when they started to fall in
infected ﬁbroblasts (Figure 4). Levels of carbamoyl-aspartate,
in contrast, increased dramatically during viral infection
starting at 24 hpi (Figure 4). While levels of carbamoyl-
aspartate increased substantially, levels of the CAD transcript
remain unchanged during the course of infection (Figure 4),
suggesting that transcriptional activation of the CAD gene is
not responsible for the accumulation of carbamoyl-aspartate.
The increased carbamoyl-aspartate levels did not appear to
arise from blockade in its utilization, as levels of pyrimidine
biosynthetic end products such as the ribonucleotides UTP
and CTP and the deoxyribonucleotide TTP were generally
Figure 4. HCMV-Induced Changes in Pyrimidine Biosynthesis
Metabolite data from mock-infected (dotted line) or virally infected (red
line) fibroblasts are plotted, with the symbolsþ, , and NC (shown in red)
over the arrows indicating changing levels of enzyme transcripts as
described in the Figure 1 legend.
doi:10.1371/journal.ppat.0020132.g004
PLoS Pathogens | www.plospathogens.org December 2006 | Volume 2 | Issue 12 | e132 1170
Metabolomics of HCMV Infectionincreased compared to mock infection (Figure 4), although
levels of UMP, which sits in the middle of pyrimidine
biosynthesis, were actually slightly decreased.
Interestingly, UTP reportedly serves as a feedback inhibitor
of CAD activity [24,25] and one would expect that the
increased levels of UTP that occur during HCMV infection
might inhibit CAD activity, thereby blocking carbamoyl-
aspartate accumulation. One possible explanation for the
continued high levels of carbamoyl-aspartate in the face of
high UTP is that infection might spatially segregate UTP and
CAD into different compartments. This might involve inter-
play between the virus and mitogen-activated protein kinase,
which has recently been shown to regulate CAD activity/
localization [26].
Another challenge in interpreting the carbamoyl-aspartate
accumulation is that the three active sites of CAD are linked
by a 96-A ˚ long channel which supposedly localizes carbamoyl-
phosphate and carbamoyl-aspartate to the interior of the
enzyme [27–29]. Thus, the presence of free carbamoyl-
aspartate may indicate profound perturbation of CAD in
infected cells, perhaps as the consequence of an interacting
virus-coded protein that results in leakage of carbamoyl-
aspartate from the enzyme interior.
Purine Homeostasis during HCMV Infection
In contrast to the aforementioned alterations of the
pyrimidine biosynthetic pathway, HCMV infection did not
dramatically affect purine metabolite pool levels. AMP, ADP,
and ATP metabolite levels did not change signiﬁcantly with
respect to mock infection, with the exception of a slight
increase in ADP and ATP at 48 h and a small accumulation of
AMP after 48 h in HCMV-infected versus mock-infected
ﬁbroblasts (Figure 5). The present study does not provide
substantial insight into de novo purine biosynthesis however,
because the only purine intermediate for which an SRM was
included, IMP, could not be measured due to interference
from naturally occurring heavy isotopes of AMP (see
Materials and Methods). While the levels of purines do not
change dramatically, it is likely that increased turnover of the
high-energy phosphate bond of ATP occurs, as the RNAs
encoding mitochondrial ATP synthases were signiﬁcantly
upregulated (Table S2).
The dramatic increase in pyrimidine versus purine levels
may reﬂect different biological roles of the two families of
metabolites. Dramatic concentration changes in ATP and
GTP could alter the balance of a multitude of enzymatic
reactions and interactions based on their widespread utiliza-
tion as signaling constituents and energy currency. As such, a
pathogen may be forced to maintain purine levels close to
normal physiological levels. Pyrimidines, in contrast, do not
have equally wide-ranging functions and thus HCMV may
have license to more dramatically inﬂuence pyrimidine levels.
HCMV Infection and Amino Acids
With the exception of alanine, HCMV infection did not
induce increased levels of other measured amino acids. While
the presence of exogenous amino acids in the medium
precluded quantiﬁcation of a number of amino acids, the
levels of glutamate were not affected by viral infection (Figure
5), nor were the levels of asparagine, aspartate, histidine, or
proline (Table S1). Taken together, these data suggest that
while HCMV infection strongly impacts the metabolite levels
of certain metabolites, it has little effect on many amino acid
levels.
Figure 6. HCMV-Induced Decreases in Selected Metabolite Pools
Metabolite data from mock-infected (dotted line) or virally infected (red
line) fibroblasts are plotted as described in the Figure 1 legend.
doi:10.1371/journal.ppat.0020132.g006
Figure 5. Homeostasis of Purine Nucleotides and Amino Acids during
HCMV Infection
Metabolite data from mock-infected (dotted line) or virally infected (red
line) fibroblasts are plotted as described in the Figure 1 legend.
doi:10.1371/journal.ppat.0020132.g005
PLoS Pathogens | www.plospathogens.org December 2006 | Volume 2 | Issue 12 | e132 1171
Metabolomics of HCMV InfectionHCMV Infection Depletes Cells of a Subset of Metabolites
A number of metabolites were found to decrease rapidly
during HCMV infection compared to mock infection of
ﬁbroblasts (Figure 6). These metabolites could be grouped
generically into those, such as adenosine and carnitine, for
which HCMV infection seemed to accelerate decreases that
also occurred during mock infection, and others, like myo-
inositol and glycerol phosphate, which decreased only in the
HCMV infection condition. Several of the metabolites
decreasing during HCMV infection were nucleosides (adeno-
sine and uridine), consistent with use of these metabolites for
nucleotide and eventually RNA or DNA biosynthesis. Others
were related to lipid metabolism: carnitine, which plays a key
role in b-oxidation of long-chain fatty acids [30,31]; glycerol-
phosphate, a precursor to the glycerol portion of phospho-
lipids, diacylglycerols, and triglycerides; and myo-inositol, a
precursor to inositol-containing lipids such as phosphatidyl-
inositol. The results for glycerol-phosphate, while unusually
noisy, were striking in that decreases were evident already at
4 hpi, making glycerol-phosphate depletion among the
e a r l i e s tk n o w ne f f e c t so fH C M Vi n f e c t i o no nc e l l u l a r
metabolism. Taken together, these results demonstrate that
HCMV infection depletes a subset of precursor metabolites,
some very rapidly, most likely utilizing them for its own
macromolecular synthesis.
Taurine, an amino acid analog involved in osmoregulation
and cell volume control [32], is not an obvious precursor
metabolite, but was nevertheless decreased 4-fold by HCMV
infection (Figure 6, top left panel). Typically, if a cell is
subjected to hypo-osmotic conditions, taurine is rapidly
transported out of the cell to compensate for the osmotic
imbalance and to prevent cell volume increase [32,33]. The
cytomegaloviruses are named for the cytopathic effect they
induce, which involves a signiﬁcant increase in cell volume. It
seems likely that taurine is not utilized by the virus, but
instead excreted by the host cell in response to the virus-
induced increase in cell volume.
HCMV-Induced Metabolite Levels Far Exceed Those Seen
in Actively Growing Cells
HCMV activates a number of cyclin-dependent kinases and
induces quiescent G0 cells to enter the G1 compartment of
the cell cycle and progress to the G1-S border [34,35]. Up to
this point, we tested the effects of HCMV infection in
conﬂuent, serum-starved G0 cells. Consequently, we were
Figure 7. Effect of HCMV on RNA Levels of Glycolytic, TCA Cycle, and Pyrimidine Biosynthetic Enzymes
Transcriptional data that passed variance analysis (ANOVA, p , 0.05).
aMore information on specific genes can be accessed using probe designations at http://www.reactome.org.
bAverage fold induction over mock infection (averaged over 24, 48, and 72 hpi).
cRepresents averaged isozyme/subunit induction over mock in cases where data for multiple isozymes/subunits exist.
doi:10.1371/journal.ppat.0020132.g007
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differences between actively growing and quiescent cells, so
we tested how the metabolic changes induced by infection of
quiescent G0 cells compared to the differences between
quiescent and actively growing cells. Toward this end, we
harvested ﬁbroblasts that were actively growing and pro-
cessed them for LC-MS/MS. Metabolite levels in actively
growing ﬁbroblasts were compared to 72-hpi, HCMV-
infected ﬁbroblasts. The relative levels of acetyl-CoA, alanine,
carbomoyl-aspartate, succinyl-CoA, and to a lesser extent
PEP, NADH, CTP, and TTP, were dramatically elevated in
HCMV-infected ﬁbroblasts compared to actively growing
ﬁbroblasts (Figure 8). Thus, HCMV does not modify the
cellular metabolome simply by inducing quiescent cells to
enter the G1 phase of the cell cycle. Rather, the virus re-
programs the metabolic status of the cell, producing a unique
signature of infection.
Conclusions and Future Directions
The network of chemical reactions involving the derivation
of energy currency and biosynthetic building blocks from
nutrient inputs consists of ;500 different compounds and
700 interconverting reactions [36]. Remarkably, relatively
little is known of how intracellular pathogens modulate these
metabolites and their interconversions. We utilized a global
approach to address this issue. As commonly occurs with such
approaches, we generated many speciﬁc biochemical hypoth-
eses that necessitate further inquiry. One such hypothesis,
that HCMV infection induces phosphofrucktokinase activity,
was veriﬁed. Many more remain untested.
Beyond speciﬁc biochemical hypotheses, we also began the
process of tackling larger biological questions regarding the
metabolic interplay between pathogens and their hosts. Can
pathogens meet their biosynthetic needs simply by activating
cellular growth pathways with a coordinate increase in
metabolic activity? This does not appear to be the case for
HCMV. Our results indicate that the virus institutes its own
metabolic program, altering normal metabolic homeostasis
maintained in quiescent and growing cells and considerably
stimulating aspects of glycolysis, the citric acid cycle, and
pyrimidine biosynthetic metabolic pathways. Future experi-
ments are necessary to determine whether the numerous
metabolic differences observed during HCMV infection are
necessary for efﬁcient viral replication, and, if so, the means
by which these metabolic alterations contribute to the virus
growth cycle.
Materials and Methods
Biological reagents. Primary human foreskin ﬁbroblasts (passages
6–10) were cultured in Dulbecco’s modiﬁed Eagle medium (DMEM)
containing 7.5% fetal calf serum and 4.5 g/L glucose. All infections
were carried out with BADwt, which is derived from a bacterial
artiﬁcial chromosome (BAC) clone of the AD169 strain of HCMV [37].
The BAC was inserted into the genome of HCMV without deletion of
any viral sequence and was excised by a co-transfected CRE
recombinase that mediates recombination at the loxP sites, which
ﬂank the BAC, leaving just the loxP site in the viral clone. This clone
has been tested in a diversity of assays and has always displayed a
wild-type AD169 phenotype.
Cell culture. Fibroblasts were grown to conﬂuence in 10-cm dishes
and maintained for 3–5 d, at which time serum-containing medium
was removed, and cells were washed once with serum-free DMEM.
After maintenance in serum-free DMEM for 24 h, cells were mock
infected or infected at a multiplicity of 3.0 pfu/ cell, and after a 2-h
adsorption period, the inoculum was aspirated and fresh serum-free
medium was added. Cells were harvested for metabolic, transcrip-
tional, or total protein analysis at various times after the initiation of
infection. Actively growing non-conﬂuent primary ﬁbroblasts were
grown in DMEM containing 7.5% dialyzed fetal calf serum and
harvested 24 h after splitting. Flow cytometric analysis of cellular
DNA content was performed as previously described [38].
Protein analysis. For total protein analysis, cells were washed with
PBS, scraped, pelleted by low speed centrifugation, and solubilized in
lysis buffer containing 150 mM KCl, 10 mM Hepes, 1% NP40, 0.5%
deoxycholate, 0.1% SDS, 10 lg/ml phenylmethylsulphonylﬂuoride
(PMSF), and 1 lg/ml pepstatin. After 10 min on wet ice, lysates were
centrifuged at 14,000 3 g for 10 min. The protein concentration of
supernatant ﬂuids was determined by using the Bradford assay (Bio-
Rad Laboratories, http://www.bio-rad.com).
Metabolite extraction. The medium was aspirated from plates
containing medium only, actively growing ﬁbroblasts, or ﬁbroblasts
that were 4, 24, 48, 72, or 96 h post-mock or post-HCMV infection.
Methanol:water 80:20 (80% methanol) at  75 8C was immediately
added to quench metabolic activity and extract metabolites. After
metabolism quenching, cells were scraped from the plastic tissue
culture dish with the dish kept on dry ice, and the resulting cell
suspension vortexed, centrifuged at 6000 3 g for 5 min, and re-
extracted twice more with 80% methanol at 75 8C. After pooling the
three extractions, the samples were completely dried under nitrogen
gas, dissolved in 200 ll 50% methanol, and spun at 13,000 3 g for 5
min to remove debris. Internal standard mix (15 ll) was added to an
aliquot of the supernatant (135 ll) and the mixture was analyzed by
LC-MS/MS as described below with the virally infected and mock-
infected samples alternated (to avoid artifacts in the measurement of
unstable compounds due to differential processing times), and all
analyses completed within 16 h of sample collection (to further
mitigate any potential problems with sample stability). The internal
standard mix was comprised of
13C-,
15N-labeled compounds (uni-
formly labeled unless otherwise indicated, from Cambridge Isotope
Laboratories, http://www.isotope.com; or Medical Isotopes, http://
www.medicalisotopes.com) in 50% methanol with 0.1% formic acid:
ATP (2 lg/ml), TTP (2 lg/ml), succinate (1,4-
13C, 1 lg/ml), threonine (1
lg/ml), glutamate (1 lg/ml), UMP (1 lg/ml), AMP (1 lg/ml), and
deoxyadenosine (0.1 lg/ml).
Phosphofrucktokinase assay. 48 h post-mock or post-HCMV
infection, cells were washed once and then scraped into ice- cold
PBS. After centrifugation at 1,000 3 g for 5 min, cell pellets were
resuspended in 200 ll 60 mM Hepes (pH 7.4), 1 mM MgCl2,5m M
DTT, 0.6 mM PMSF, and 40 mM NaF. Cellular suspensions were
Figure 8. HCMV Infection Disrupts Normal Homeostatic Metabolite Pool
Levels
Metabolite levels in HCMV-infected quiescent fibroblasts (72 hpi) and
actively growing fibroblasts are reported as fold-induction over
quiescent, uninfected cells (mock 4 h). To account for differences in
cell count and cell size between conditions, all results are normalized to
total protein levels. Bars represent the mean fold-induction from two
independent experiments performed in duplicate (n ¼ 4), with the error
bars showing þ1 SE of the mean.
doi:10.1371/journal.ppat.0020132.g008
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remove insoluble debris. ATP (ﬁnal concentration 1.8 mM), iodoa-
cetate (ﬁnal concentration 150 lM), and fructose 6-phosphate (ﬁnal
concentration 1.8 mM) were added immediately, prior to starting the
reaction by incubation at 37 8C, with the iodoacetate serving to
inhibit the downstream glycolytic enzyme, glyceraldehyde 3-phos-
phate dehydrogenase. Reactions were stopped at various times by
sampling 20 ll and adding 120 ll 80% methanol. Samples were spun
at 13,0003g for 5 min to remove debris. Internal standard mix (15 ll)
was added to an aliquot of the supernatant (120 ll) and the mixture
was analyzed for FBP accumulation by LC-MS/MS as described below.
The resulting data were ﬁt to a single-exponential curve describing
saturable product formation with pseudo ﬁrst-order kinetics:
SðtÞ¼Smaxð1   e ktÞ
(This maximally simple curve ﬁt approximates Michaelis-Menten
kinetics for a single substrate with Km . [substrate].) The data ﬁt the
curve very well for both the infected (R
2 ¼ 0.998) and uninfected
samples (R
2¼0.993), with Smax values equal to 2.3310
4 (infected) and
3.5310
4 (uninfected) and an ;6-fold difference in k (0.0405 6 0.002
versus 0.0066 6 0.001), which translates into a corresponding ;4-fold
difference in initial velocity given the proportionality of initial
velocity to k*Smax.
LC-MS/MS instrumentation. LC-MS/MS was performed using an
LC-10A HPLC system (Shimadzu, http://www.shimadzu.com) and a
Luna aminopropyl column (250 mm 3 2 mm with a 5-lm particle
size from Phenomenex, http://www.phenomenex.com) coupled to the
mass spectrometer. The LC parameters were as follows: autosampler
temperature, 4 8C; injection volume, 20 lL; column temperature, 15
8C; and ﬂow rate, 150 lL/min. The LC solvents were Solvent A: 20
mM ammonium acetate þ 20 mM ammonium hydroxide in 95:5
water:acetonitrile (pH 9.45); and Solvent B: acetonitrile. The
gradients are as follows: positive mode—t ¼ 0, 85% B; t ¼ 15 min,
0% B; t ¼ 28 min, 0% B; t ¼ 30 min, 85% B; t ¼ 40 min, 85% B; and
negative mode—t ¼ 0, 85% B; t ¼ 15 min, 0% B; t ¼ 38 min, 0% B; t
¼ 40 min, 85% B; t ¼ 50 min, 85% B.
Mass spectrometric analyses were performed on a Finnigan TSQ
Quantum Ultra triple-quadrupole mass spectrometer (Thermo
Electron Corporation, http://www.thermo.com), equipped with an
electrospray ionization (ESI) source. ESI spray voltage was 3,200 V in
positive mode and 3,000 V in negative mode. Nitrogen was used as
sheath gas at 30 psi and as the auxiliary gas at 10 psi, and argon as the
collision gas at 1.5 mTorr, with the capillary temperature 325 8C. Scan
time for each SRM transition was 0.1 s with a scan width of 1 m/z. The
LC runs were divided into time segments, with the SRM scans within
each time segment limited to those compounds eluting during that
time interval. For compounds eluting at the boundaries between time
segments, the SRM scan corresponding to the compound is
conducted in both time segments. The instrument control, data
acquisition, and data analysis were performed by the Xcalibar
software (Thermo Electron Corporation, version 1.4 SR1), which also
controlled the chromatography system.
Metabolite data analysis. To quantify metabolite levels, peak
heights for 167 different metabolite SRMs were determined for each
sample. A metabolite was not analyzed further if: (i) its signal for all
viral and mock samples was undetectable; (ii) its maximum signal for
all viral or mock samples was less than 5-fold that of the maximum
signal in the media-alone plates; or (iii) the observed signal likely
resulted from a naturally occurring heavy isotope of another
metabolite. The last exclusion was implemented, since, if two
compounds have similar retention times and fragmentation patterns,
the signal for an abundant compound, e.g., AMP, can be potentially
mistaken for a less abundant, slightly heavier compound, e.g., IMP,
due to naturally occurring
13C, which makes a proportion of AMP
heavier and thus potentially contributes to the signal in the IMP SRM.
Of the 167 compounds tested, 63 met criteria for further analysis.
Metabolite signal levels represent the average from two different
experiments performed in duplicate (n ¼ 4). When signals were
undetectable or less than 100 for a given sample, they were assigned a
signal level of 100, the approximate level of instrument noise. To
approximate intracellular concentrations, metabolite signals from
each sample were then normalized to 500 lg of total protein (the
approximate amount found in the samples) based on the measured
total protein level of the corresponding sample (as determined by the
Bradford assay). All four measurements (already protein-normalized)
taken from the mock-infected cells at 4 h were then averaged to yield
a basal signal for each metabolite (Signalbasal). Fold changes (and their
associated SE) relative to this basal signal were then calculated for
each sampling time point separately for the viral and mock infection:
Fold change
¼
Average ðProtein-normalized signals for the metabolite;n ¼ 4Þ
Signalbasal
SE of fold change
¼
SE ðProtein-normalized signals for the metabolite;n ¼ 4Þ
Signalbasal
Array analysis. At 4, 24, 48, or 72 h post-mock or post-HCMV
infection, medium was aspirated and RNA was prepared using Trizol
as recommended by the manufacturer (Invitrogen, http://www.
invitrogen.com) and subsequently puriﬁed through an RNAeasy
column (Quiagen, http://www1.qiagen.com). Fluorescent cRNA (Cy3
and Cy5) was prepared from all samples, as well as a control RNA set
(human universal reference total RNA from Clontech, http://www.
clontech.com) using the Low RNA Linear Ampliﬁcation Kit (Agilent,
http://www.agilent.com) as per manufacturer’s instructions. Inde-
pendent duplicate samples were dye reversed and sample cRNA was
mixed with alternatively labeled (Cy3 versus Cy5) control cRNA and
hybridized to Human Whole Genome Oligo Microarray as per the
manufacturer’s instructions (Agilent). Slides were scanned with an
Agilent Scanner (model number G2505B) and data were extracted
with Feature Extractor 7.5 software. The resulting data ﬁles were
imported into Genespring GX 7.3. The recorded ﬂuorescent values
were then subjected to the default per-chip and per-gene Lowess
normalization with the cross-gene error model active. Only probe sets
whose ﬂuorescent signal was ﬂagged as present or unknown were
examined. Probe sets were further ﬁltered by control channel
expression; all probes with a cRNA control signal of less than 33
ﬂuorescent units were not analyzed further. Analysis of variance
(ANOVA) was then performed on the remaining probes using mock
versus HCMV infection as the parameter, and grouping the mock 24-,
48-, and 72-h time points together and the HCMV-infected 24-, 48-,
and 72-h time points together. The 4-h time points were left out as
there was little change between mock- and HCMV-infected metabolic
genes at this time point. The Welsh ANOVA analysis was performed
using error model variances and Benjamini/Hochberg multiple
testing correction with a p-value cutoff of 0.05. Probe sets as listed
in the text and Figure 7 can be linked with corresponding gene
information through: http://www.reactome.org.
Quantitative real-time PCR. RNA used for qRT-PCR was isolated as
described above for array analysis. cDNA synthesis was performed
utilizing TaqMan Reverse Transcription reagents with random
hexamers as per the manufacturer’s protocol (Applied Biosystems,
http://www.appliedbiosystems.com). qPCR was performed using the
Power Sybr Green PCR Master Mix, 7900HT Sequence Detection, and
SDS software version 2.1 (Applied Biosystems) following the manu-
facturer’s instructions. Metabolic transcripts were quantiﬁed with
speciﬁc primer pairs as follows: the phosphofructokinase-1 transcript
(A_23_P46928) with 59 AGCTGTATTCAGAAGAGGGCAAAG 39
and 59 CCACCCTGCTGCATGTGA39; the pyruvate dehydrogenase
transcript (A_23_P251095) with 59 GACGAAAAGGAGGTTGT
GCTAAAG 39 and 59 CCATTGCCCCCGTAGAAGTT 39; and the
pyruvate kinase transcript (A_32_P147241) with 59 CCGCCTGGA-
CATTGATTCAC 39 and 59 GGGC CAATGGTACAGATGATG 39. The
GAPDH transcript (A_23_P13899) has been shown to remain
constant during HCMV infection [39] and its ampliﬁcation, with the
primers: 59 ACCCACTCCTCCACCTTTGAC 39 and 59-
CTGTTGCTGTAGCCAAATTCGT 39 was used for normalization
purposes. Relative quantiﬁcation with a standard curve for each
primer pair was performed as described in the ABI prism 7900HT
sequence detection system guide (Applied Biosystems). A dissociation
curve was generated for each reaction and demonstrated ampliﬁca-
tion of a single product. Reactions were performed in duplicate, and
non-template controls were included for each primer pair.
Supporting Information
Figure S1. DNA Content of Actively Growing or Quiescent Cells
Found at doi:10.1371/journal.ppat.0020132.sg001 (57 KB PPT).
Figure S2. Isotope-Labeled Internal Standard Controls
Isotope-labeled internal standards were added to mock- (dotted line)
and HCMV-infected (red line) samples prior to measurement as
described in Materials and Methods. Average SRM peak heights (n ¼
4) and the standard error of their means were plotted relative to the
mock 4-hr internal standards on a log2 axis.
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Table S1. Effect of HCMV on Metabolite Levels
Found at doi:10.1371/journal.ppat.0020132.st001 (49 KB XLS).
Table S2. Effect of HCMV on RNA Levels of ATP Syntheses
(Mitochondrial Proton Transporting)
Found at doi:10.1371/journal.ppat.0020132.st002 (46 KB PPT).
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